| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| ACCOUNTING | 5,000 |
| Name | Date Acquired | How Acquired | Date Sold | Purchaser Name | Gross Sales Price | Basis | Basis Method | Sales Expenses | Total (net) | Accumulated Depreciation |
|---|---|---|---|---|---|---|---|---|---|---|
| IMMUNOGEN INC | 2014-12 | PURCHASE | 2024-02 | 31,260 | 15,755 | 15,505 | ||||
| IMMUNOGEN INC | 2015-01 | PURCHASE | 2024-02 | 93,780 | 23,450 | 70,330 | ||||
| IMMUNOGEN INC | 2015-09 | PURCHASE | 2024-02 | 93,780 | 30,113 | 63,667 |
| Name of Stock | End of Year Book Value | End of Year Fair Market Value |
|---|---|---|
| STOCKS & FUNDS W/BROKERAGE FIRM | 2,645,801 | 2,645,801 |
| Description | Revenue and Expenses per Books | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| EXPENSES | ||||
| BROKERAGE FEES | 38,884 | |||
| OTHER EXPENSES | 300 |
| Description | Revenue And Expenses Per Books | Net Investment Income | Adjusted Net Income |
|---|---|---|---|
| MORGAN STANLEY 815110507493 | 70 |
| Description | Amount |
|---|---|
| SETP UP (DOWN BASIS ON SALE | 261,421 |